Physician Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Physician Wealth Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.24K	Buy	109 +44	+68%	+$2.41K	﹤0.01%	1010
2026 Q1	$3.67K	Hold	65	–	–	﹤0.01%	1112
2025 Q4	$3.86K	Hold	65	–	–	﹤0.01%	1059
2025 Q3	$3.52K	Sell	65 -41	-39%	-$2.35K	﹤0.01%	1025
2025 Q2	$5.83K	Sell	106 -10	-9%	-$589	﹤0.01%	760
2025 Q1	$8.2K	Buy	116 +10	+9%	+$673	﹤0.01%	645
2024 Q4	$6.97K	Buy	+106	New	+$7.1K	﹤0.01%	688

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Physician Wealth Advisors's BMRN Position: Q2 2026 in Review

Physician Wealth Advisors increased its BioMarin Pharmaceuticals (BMRN) stake by 68% in Q2 2026, buying an estimated $2.41K and bringing the position to 109 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Physician Wealth Advisors first reported a position in BMRN in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.2K in Q1 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Physician Wealth Advisors held 109 shares of BioMarin Pharmaceuticals worth $6.24K as of Q2 2026.
Physician Wealth Advisors bought 44 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $2.41K.
BioMarin Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1010 holding.
Physician Wealth Advisors first reported a position in BioMarin Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's BioMarin Pharmaceuticals position peaked at $8.2K in Q1 2025.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.